Tablets & Capsules

TC0915

Issue link: https://www.e-digitaleditions.com/i/571156

Contents of this Issue

Navigation

Page 19 of 65

18 September 2015 Tablets & Capsules Figure 3 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 Ejection force versus compaction pressure for placebo and active tablets 200 195 190 185 180 175 170 165 160 155 150 145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 500 mg 600mg Retalac (0.25) Retalac (0.5) Main compression (MPa) Ejection force (N) Figure 4 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480 490 500 510 520 530 540 550 560 570 Tensile strength-compaction pressure ratio versus tangential velocity of tablet press turret 11 10 9 8 7 6 5 4 3 500 mg Tangential velocity (mm/sec) Tensile strength-compaction pressure ratio (1/1000th)

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0915